NCT06751667View on ClinicalTrials.gov

Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2032

Conditions
Bladder (Urothelial, Transitional Cell) CancerBladder CancerBladder TumorsBladder Cancer RecurrenceCystoscopy
Interventions
DEVICE

Urinary biomarkers

In a bid to reduce or replace surveillance cystoscopies multiple urinary biomarkers have been evaluated for the follow-up of the bladder cancer patients. These device will reduce the number of cystoscopies

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER